ALAN COLVIN: Open Payments
NPI 1033879150 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$799 in 42 payments from 17 companies in 2025. Trend: 2023 $259 · 2024 $657 · 2025 $799
Food & beverage: $799
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $169 |
| ABBVIE INC. | 4 | $97 |
| Astellas Pharma US Inc | 3 | $68 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| Lilly USA, LLC | 3 | $52 |
| Exact Sciences Corporation | 2 | $43 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Dexcom, Inc. | 2 | $35 |
| PFIZER INC. | 2 | $33 |
Products named: Wegovy, VRAYLAR, Veozah, MOUNJARO, AIRSUPRA, Ozempic, The Cologuard Plus Collection Kit, Auvelity.
Industry payments across NC — which companies pay providers there.
